Trump to nominate Scott Gottlieb as FDA commissioner despite industry links.

Abstract

The White House announced on 10 March that President Trump will nominate Scott Gottlieb to head the US regulatory body, the Food and Drug Administration. Gottlieb has extensive ties to the drug and biologics industry and has long supported deregulation of the FDA. 2 The US watchdog group, Public Citizen, reports that Gottlieb has received “at least $413 000… (More)
DOI: 10.1136/bmj.j1339

Topics

  • Presentations referencing similar topics